SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : McKesson HBOC (MCK)
MCK 840.61-0.4%Jan 16 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom_ who wrote (61)4/30/1999 12:21:00 PM
From: Doug  Read Replies (1) of 165
 
Tom: I seemed to have missed something. The C Sales todate were

a: 4th Q 99 ---$26.6m

b: 1st Q00 ---$16m

The gross shortfall publicly known is $42.6m.

There are near 279m shares. MCK has stated that the short fall will be 50c to allow for the C sales and the reduction in future Sales.

The total revenue shortfall due to C sales and reduction in sales during Y2K are in fact much greater viz near $150m. This might increase because some C sales swill have to be written off and also
because Retailers and their clients seing them in trouble will badger them to lower their prices.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext